DFDA

Ustekinumab

Treatment used for 4 conditions

Total Trials
304
Total Participants
40K
Avg Effectiveness
76%
Avg Safety Score
58%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.

Psoriasis
Effectiveness:80%
Safety:57%
Trials:94
Participants:20K
Inflammatory bowel disease
Effectiveness:77%
Safety:60%
Trials:100
Participants:10K
Crohn's Disease
Effectiveness:72%
Safety:50%
Trials:78
Participants:8K
Ulcerative Colitis
Effectiveness:75%
Safety:65%
Trials:32
Participants:2K